Cargando…

High CLEC-2 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma

We enrolled a total of 277 patients who received nephrectomy due to clear cell renal cell carcinoma (ccRCC) in Zhongshan Hospital from Jan 2005 to Jun 2007. Immunohistochemistry was performed to evaluate the impact of CLEC-2 positive cell infiltration on the overall survival (OS) and recurrence-free...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xiong, Ying, Liu, Li, Xia, Yu, Wang, Jiajun, Xi, Wei, Bai, Qi, Qu, Yang, Long, Qilai, Xu, Jiejie, Guo, Jianming
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325393/ https://www.ncbi.nlm.nih.gov/pubmed/27564117 http://dx.doi.org/10.18632/oncotarget.11606

Ejemplares similares

Low CCL-21 expression associates with unfavorable postoperative prognosis of patients with metastatic renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2016)

Low CCL17 expression associates with unfavorable postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xiong, Ying, et al.
Publicado: (2017)

Dectin-1 predicts adverse postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2016)

Dot1l expression predicts adverse postoperative prognosis of patients with clear-cell renal cell carcinoma
por: Qu, Yang, et al.
Publicado: (2016)

IRF5 is associated with adverse postoperative prognosis of patients with non-metastatic clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2017)

Enrichment of C5a-C5aR axis predicts poor postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xi, Wei, et al.
Publicado: (2016)

Decreased expression of JMJD3 predicts poor prognosis of patients with clear cell renal cell carcinoma
por: Wang, Jiajun, et al.
Publicado: (2017)

Podoplanin associates with adverse postoperative prognosis of patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2016)

Prognostic value of copper transporter 1 expression in patients with clear cell renal cell carcinoma
por: Xia, Yu, et al.
Publicado: (2017)

Prognostic significance of ST6GalNAc-1 expression in patients with non-metastatic clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2016)

Prognostic significance of ST3GAL-1 expression in patients with clear cell renal cell carcinoma
por: Bai, Qi, et al.
Publicado: (2015)

High Level of Anaphylatoxin C5a Predicts Poor Clinical Outcome in Patients with Clear Cell Renal Cell Carcinoma
por: Xi, Wei, et al.
Publicado: (2016)

Decreased Expression of SETD2 Predicts Unfavorable Prognosis in Patients With Nonmetastatic Clear-Cell Renal Cell Carcinoma
por: Liu, Weisi, et al.
Publicado: (2015)

Tumor-infiltrating TNFRSF9(+) CD8(+) T cells define different subsets of clear cell renal cell carcinoma with prognosis and immunotherapeutic response
por: Li, Yaohui, et al.
Publicado: (2020)

Prognostic value of CC-chemokine receptor seven expression in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitor
por: Xia, Yu, et al.
Publicado: (2017)

CLEC3B is downregulated and inhibits proliferation in clear cell renal cell carcinoma
por: Liu, Jian, et al.
Publicado: (2018)

PD-L1 expression in renal cell carcinoma clear cell type is related to unfavorable prognosis
por: Leite, Katia R M, et al.
Publicado: (2015)

High expression of TTC21A predicts unfavorable prognosis and immune infiltrates in clear cell renal cell carcinoma
por: Lin, Junhao, et al.
Publicado: (2022)

Intratumoral CXCL13(+)CD8(+)T cell infiltration determines poor clinical outcomes and immunoevasive contexture in patients with clear cell renal cell carcinoma
por: Dai, Siyuan, et al.
Publicado: (2021)

CD47 Expression Predicts Unfavorable Prognosis in Clear Cell Renal Cell Carcinoma after Curative Resection
por: Park, Hosub, et al.
Publicado: (2022)

Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma
por: Laba, Pingcuo, et al.
Publicado: (2018)

Identification and validation of dichotomous immune subtypes based on intratumoral immune cells infiltration in clear cell renal cell carcinoma patients
por: Xiong, Ying, et al.
Publicado: (2020)

CCR5 blockade inflames antitumor immunity in BAP1-mutant clear cell renal cell carcinoma
por: Zhou, Quan, et al.
Publicado: (2020)

APOBEC3G expression correlates with unfavorable prognosis and immune infiltration in kidney renal clear cell carcinoma
por: Peng, Ting, et al.
Publicado: (2022)

High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma
por: Xu, Zhiying, et al.
Publicado: (2016)

Prognostic Value of EZH2 Expression and Activity in Renal Cell Carcinoma: A Prospective Study
por: Liu, Li, et al.
Publicado: (2013)

RIPK2 is an unfavorable prognosis marker and a potential therapeutic target in human kidney renal clear cell carcinoma
por: Li, Diangeng, et al.
Publicado: (2021)

Prognostic role of N-Acetylgalactosaminyltransferase 10 in metastatic renal cell carcinoma
por: Liu, Li, et al.
Publicado: (2017)

Decreased interferon regulatory factor 6 expression due to DNA hypermethylation predicts an unfavorable prognosis in clear cell renal cell carcinoma
por: Li, Zhi, et al.
Publicado: (2021)

Increased Nrf2 expression by renal cell carcinoma is associated with postoperative chronic kidney disease and an unfavorable prognosis
por: Yuki, Hideo, et al.
Publicado: (2018)

Granulocyte macrophage colony-stimulating factor predicts postoperative recurrence of clear-cell renal cell carcinoma
por: Chang, Yuan, et al.
Publicado: (2016)

An immature inhibin‐α‐expressing subpopulation of ovarian clear cell carcinoma cells is related to an unfavorable prognosis
por: Kusumoto, Shinya, et al.
Publicado: (2021)

FCER1G positively relates to macrophage infiltration in clear cell renal cell carcinoma and contributes to unfavorable prognosis by regulating tumor immunity
por: Dong, Keqin, et al.
Publicado: (2022)

High expression of FUT3 is linked to poor prognosis in clear cell renal cell carcinoma
por: Meng, Li, et al.
Publicado: (2017)

High expression of interleukin-11 is an independent indicator of poor prognosis in clear-cell renal cell carcinoma
por: Pan, Deng, et al.
Publicado: (2015)

Low Expression of Mucin-4 Predicts Poor Prognosis in Patients With Clear-Cell Renal Cell Carcinoma
por: Fu, Hangcheng, et al.
Publicado: (2016)

Systemic inflammation score predicts postoperative prognosis of patients with clear-cell renal cell carcinoma
por: Chang, Y, et al.
Publicado: (2015)

Tumor cell PD-L1 expression is a strong predictor of unfavorable prognosis in immune checkpoint therapy-naive clear cell renal cell cancer
por: Möller, Katharina, et al.
Publicado: (2021)

Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma
por: Niu, Tian, et al.
Publicado: (2016)

P2X7 receptor predicts postoperative cancer-specific survival of patients with clear-cell renal cell carcinoma
por: Liu, Zheng, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_h9lgj4e31ebu8v45clj24cfna9